Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Pagliaro

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of Hematology & Oncology|January 7, 2021
Targeting oncogenic Notch signaling with SERCA inhibitorsLuca Pagliaro, Matteo Marchesini, Giovanni Roti
Cells|October 2, 2020
Targeting Notch Trafficking and Processing in CancersLuca Pagliaro, Claudia Sorrentino, Giovanni Roti
Current Opinion in Oncology|August 26, 2022
Modern treatment approaches to adult acute T-lymphoblastic and myeloid/T-lymphoblastic leukemia: from current standards to precision medicineMatteo Leoncin, Roberta La Starza, Giovanni Roti, et al.
International Journal of Molecular Sciences|April 17, 2025
Nidogen-1, a Player in KMT2A-Rearranged Pediatric Acute Myeloid LeukemiaJolien Vanhooren, Larissa Deneweth, Luca Pagliaro, et al.
Nature Reviews. Disease Primers|June 13, 2024
Acute lymphoblastic leukaemiaLuca Pagliaro, Sai-Juan Chen, Daniel Herranz, et al.
Leukemia|March 24, 2018
The -2518 A/G polymorphism of the monocyte chemoattractant protein-1 as a candidate genetic predisposition factor for secondary myelofibrosis and biomarker of disease severityElena Masselli, Cecilia Carubbi, Benedetta Cambò, et al.
European Journal of Medicinal Chemistry|July 18, 2024
Discovery of a new 1-(phenylsulfonyl)-1H-indole derivative targeting the EphA2 receptor with antiproliferative activity on U251 glioblastoma cell lineLorenzo Guidetti, Riccardo Castelli, Alfonso Zappia, et al.
Hematological Oncology|April 2, 2026
Ibrutinib Dose Adjustment Does Not Impair Treatment Outcome in Mantle Cell Lymphoma: An Italian Real-Life Multicenter Experience. Results From the REDOT_MCL StudyFrancesca Maria Quaglia, Lara Mannelli, Luca Pagliaro, et al.
Journal of Hematology & Oncology|January 8, 2026
Multicenter real-life evaluation of the Post-CAR prognostic index for patients with large B-cell lymphoma after CAR-T failureMirko Farina, Elena Maiolo, Chiara Ghiggi, et al.
International Journal of Molecular Sciences|January 23, 2024
CAD204520 Targets <i>NOTCH1</i> PEST Domain Mutations in Lymphoproliferative DisordersLuca Pagliaro, Elisa Cerretani, Federica Vento, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Hematology & Oncology|January 7, 2021
Targeting oncogenic Notch signaling with SERCA inhibitorsLuca Pagliaro, Matteo Marchesini, Giovanni Roti
Cells|October 2, 2020
Targeting Notch Trafficking and Processing in CancersLuca Pagliaro, Claudia Sorrentino, Giovanni Roti
Current Opinion in Oncology|August 26, 2022
Modern treatment approaches to adult acute T-lymphoblastic and myeloid/T-lymphoblastic leukemia: from current standards to precision medicineMatteo Leoncin, Roberta La Starza, Giovanni Roti, et al.
International Journal of Molecular Sciences|April 17, 2025
Nidogen-1, a Player in KMT2A-Rearranged Pediatric Acute Myeloid LeukemiaJolien Vanhooren, Larissa Deneweth, Luca Pagliaro, et al.
Nature Reviews. Disease Primers|June 13, 2024
Acute lymphoblastic leukaemiaLuca Pagliaro, Sai-Juan Chen, Daniel Herranz, et al.
Leukemia|March 24, 2018
The -2518 A/G polymorphism of the monocyte chemoattractant protein-1 as a candidate genetic predisposition factor for secondary myelofibrosis and biomarker of disease severityElena Masselli, Cecilia Carubbi, Benedetta Cambò, et al.
European Journal of Medicinal Chemistry|July 18, 2024
Discovery of a new 1-(phenylsulfonyl)-1H-indole derivative targeting the EphA2 receptor with antiproliferative activity on U251 glioblastoma cell lineLorenzo Guidetti, Riccardo Castelli, Alfonso Zappia, et al.
Hematological Oncology|April 2, 2026
Ibrutinib Dose Adjustment Does Not Impair Treatment Outcome in Mantle Cell Lymphoma: An Italian Real-Life Multicenter Experience. Results From the REDOT_MCL StudyFrancesca Maria Quaglia, Lara Mannelli, Luca Pagliaro, et al.
Journal of Hematology & Oncology|January 8, 2026
Multicenter real-life evaluation of the Post-CAR prognostic index for patients with large B-cell lymphoma after CAR-T failureMirko Farina, Elena Maiolo, Chiara Ghiggi, et al.
International Journal of Molecular Sciences|January 23, 2024
CAD204520 Targets <i>NOTCH1</i> PEST Domain Mutations in Lymphoproliferative DisordersLuca Pagliaro, Elisa Cerretani, Federica Vento, et al.
Pageof 2